BioPharma Resources

Drug Trial Radar · NCT07481630

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Knee Osteoarthritis (AMAZE 5)

Last checked: Nov 19, 2026Latest source record: Jul 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Apr 13, 2026

Primary completion

Aug 14, 2028

Study completion Aug 14, 2028

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Mar 19, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight and knee osteoarthritis. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.

Conditions

  • Obesity
  • Knee Osteoarthritis (OA)

Interventions

  • NNC0487-0111Drug

    NNC0487-0111 dose level 1 and dose level 2 will be administered subcutaneously using PDS290 pre-filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.

  • Placebo (matched to NNC0487-0111 )Drug

    Placebo matched to NNC0487-0111 will be administered subcutaneously using PDS290 pre-filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relative change in body weightTime frame: From baseline (week 0) to (week 80)
  2. Change in WOMAC Osteoarthritis Index NRS 3.1 (24-hour) (WOMAC) pain scoreTime frame: From baseline (week 0) to (week 80)

Locations

82 sites in 10 countries. Site status is shown where the registry gives one.

  • Arizona Research Center, Inc.

    Phoenix, Arizona · Recruiting

  • Diablo Clinical Research, Inc.

    Walnut Creek, California · Recruiting

  • Chase Medical Research LLC

    Hamden, Connecticut · Recruiting

  • Chase Medical Research LLC

    Waterbury, Connecticut · Recruiting

  • Zenith clinical research

    Hollywood, Florida · Recruiting

  • CNS Healthcare

    Jacksonville, Florida · Recruiting

  • Angels Clinical Research Institute

    Miami Lakes, Florida · Recruiting

  • Hope Clin Res & Wellness

    Conyers, Georgia · Recruiting

  • CenExel iResearch, LLC

    Decatur, Georgia · Recruiting

  • Elite Clinical Trials

    Blackfoot, Idaho · Recruiting

  • MedVadis Research Watertown

    Waltham, Massachusetts · Recruiting

  • Jubilee Clinical Research, Inc.

    Las Vegas, Nevada · Recruiting

  • Great Lakes Medical Research

    Westfield, New York · Recruiting

  • Accellacare and KDCILM, LLC

    Wilmington, North Carolina · Recruiting

  • Coastal Carolina Res Ctr

    North Charleston, South Carolina · Recruiting

  • VIP Trials_San Antonio

    San Antonio, Texas · Recruiting

  • Charlottesville Med Research

    Charlottesville, Virginia · Recruiting

  • Health Res of Hampton Roads

    Newport News, Virginia · Recruiting

  • Northwest Clinical Research Center

    Bellevue, Washington · Recruiting

  • Emeritus Research Sydney

    Botany, New South Wales, Australia · Recruiting

  • Momentum Clinical Research Darlinghurst

    Darlinghurst, New South Wales, Australia · Recruiting

  • Kolling Institute

    St Leonards, New South Wales, Australia · Recruiting

  • Heart of Australia

    Chelmer, Queensland, Australia · Recruiting

  • Coastal Digestive Health

    Maroochydore, Queensland, Australia · Recruiting

  • UMHAT Sveti Georgi EAD, Plovdiv

    Plovdiv, Bulgaria · Recruiting

  • MC Dr. Atanasov EOOD

    Sofia, Bulgaria · Recruiting

  • MC Excelsior OOD

    Sofia, Bulgaria · Recruiting

  • UMHAT Tsaritsa Yoanna - ISUL EAD, Orthopaedics and Traumatology

    Sofia, Bulgaria · Recruiting

  • MMA MHAT - Sofia, Rheumatology clinic

    Sofia, Bulgaria · Recruiting

  • UMHAT Sveti Ivan Rilski EAD, Rheumatology

    Sofia, Bulgaria · Recruiting

  • Alpha Recherche Clinique - Lebourgneuf

    Québec, Canada · Recruiting

  • Laser Rejuvenation Clinics Inc.

    Calgary, Alberta, Canada · Recruiting

  • Dawson Clinical Research

    Guelph, Ontario, Canada · Recruiting

  • Hamilton Medical Rsrch Grp

    Hamilton, Ontario, Canada · Not yet recruiting

  • Centre de Recherche Musculo

    Trois-Rivières, Quebec, Canada · Recruiting

  • Aarhus Universitetshospital - Klinik for Led og bindevævssygdomme

    Aarhus N, Denmark · Recruiting

  • Frederiksberg Hospital - Parker Institutet (Artrose)

    Frederiksberg, Denmark · Recruiting

  • Sanos Clinic - Herlev

    Herlev, Denmark · Recruiting

  • Laiko General Hospital Of Athens - 1st department of Internal Medicine

    Athens, Greece · Recruiting

  • Athens Medical Center S.A. (Iatriko Psychikou) - Department of Internal Medicine & Metabolic Diseases

    Athens, Greece · Recruiting

Showing 40 of 82 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.